Peripheral Medical Education


In-Person Courses

In-Person Courses maximize hands-on time to help improve skills and address clinical, technical, and procedural challenges in care. Looking for our Coronary in-person courses? Find them here.

Discover more and download the course catalog for a comprehensive list of our medical education programs.

Advanced Skills Courses

These courses are designed for Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists who want to practice complex treatment plans, procedures, and skills to improve their mastery of crucial aspects of patient care.

EndoMasters™ Medical Education Program

The focus of this course is on the diagnosis and treatment of complex endovascular lesions and understanding clinical practices that will facilitate consistent, high-quality therapy delivery for patients with Peripheral Artery Disease (PAD), venous disease, SFA disease, and more.

The multi-disciplinary Faculty use a practical, case-based approach to endovascular interventions to enhance the attendee's understanding of evaluating vascular access for a variety of interventions and formulating treatment algorithms that can be used in everyday practice.

Hands-on workshops cover guide wires, Supera™ Peripheral Stent deployment, mechanical thrombectomy, vessel closure, and cadaveric SFA/peroneal, tibial, and pedal access.

Designed For: Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists looking to improve skills and increase the complexity of the disease they are treating.

2.5 days


Our Specialty Courses offer deeper dives on specific topics with a focus on improving patient outcomes by addressing specific clinical, technical and procedural challenges in endovascular care.

Carotid Fundamentals

This course offers didactic algorithm training with participant discussion, case-based learning and hands-on workshops that focus on the tools to tackle clinical challenges and to review the indications for use of Abbott’s carotid products in today’s environment.

Completion of this course will satisfy the training requirement for Abbott’s carotid stent systems. Please speak with your Abbott representative post-course about your 3 supervised cases to complete the training process. Completion of this course will satisfy the first steps of the FDA required product training for Abbott’s carotid products.

Designed For: Interventional Cardiologistis, Vascular Surgeons, Interventional Radiologists, Interventional Neuroradiologists, Neurologists, and other physician specialties with an interest in Carotid Artery Stenting.
2 days
Carotid Fundamentals

Endovascular Proctorship Program

A specialized training opportunity limited to 1-2 trainees (and no more than 4) with a faculty proctor. Clinical areas of focus can include: Endovascular treatment of SFA/popliteal disease, carotid artery stenting, and vessel closure techniques. Virtual sessions available.

Designed For: Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists with specific interests for local or individualized training to enhance their own skill set.
1-2 days
Endovascular Proctorships Program

Vessel Closure

These courses may cover didactic topics such as safe femoral arterial, venous and alternative access techniques / potential complications. Workshops may include ultrasound and hands-on deployment of vascular closure devices.

Workshops at this program that are related to Abbott’s vessel closure products do not satisfy the device training requirements.

Designed For: Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists who would like to improve their technical skills for large-bore access and closure.
Vessel Closure
Training and Education

Cardiovascular Training & Education

Online education

Peripheral Medical Education

Download Brochure

Download Course Catalog

MAT-2102232 v4.0

Important Safety Information

Supera™ Peripheral Stent System



The Supera™ Peripheral Stent System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and / or proximal popliteal artery with reference vessel diameters of 4.0 to 7.5 mm, and lesion lengths up to 140 mm.


The Supera™ Peripheral Stent System is contraindicated in:

  • Patients who are judged to have a lesion that prevents complete inflation of an angioplasty balloon or proper placement of the stent or stent delivery system.
  • Patients who cannot receive antiplatelet or anticoagulation therapy. Based on in vivo thrombogenicity testing, the device should not be used in patients who cannot be anticoagulated as there may be some thrombus formation in the absence of anticoagulation.


  • This device is intended for single-use only. Do not reuse. Do not resterilize. Do not use if the package is opened or damaged.
  • Use this device prior to the “Use By” date as specified on the device package label. Store in a dry, dark, cool place.
  • DO NOT use if it is suspected that the sterility of the device has been compromised.
  • Persons with known hypersensitivities to Nitinol and / or its components (e.g. nickel-titanium) may suffer an allergic reaction to this implant.
  • Administer appropriate antiplatelet therapy pre- and post-procedure.
  • Careful attention should be paid when sizing and deploying the stent to prevent stent elongation. In the SUPERB clinical study, stent elongation was associated with a decrease in patency at 12 months.


The Supera™ Peripheral Stent System should only be used by physicians and medical personnel trained in vascular interventional techniques and trained on the use of this device.

  • The long-term safety and effectiveness of the Supera™ Peripheral Stent System has not been established beyond three years.
  • The safety and effectiveness of the Supera™ Peripheral Stent System has not been established in patients who:
    • are less than 18 years old
    • are pregnant or lactating
    • have in-stent restenosis of the target lesion
    • have known hypersensitivity to any component of the stent system (e.g., nickel)
    • cannot tolerate contrast media and cannot be pre-treated
    • have uncontrolled hypercoagulability and / or another coagulopathy
  • This device is not designed for use with contrast media injection systems or power injection systems.
  • The flexible design of the Supera™ stent may result in variation in the deployed stent length.


Magnetic Resonance Imaging (MRI) Safety Information

Nonclinical testing has demonstrated that the Supera™ stent, in single and in overlapped configurations up to 250 mm in length, is MR Conditional. A patient with this device can be safely scanned in an MR system meeting the following conditions:

  • Static magnetic field of 1.5 or 3.0 Tesla
  • Maximum spatial gradient magnetic field of 2,500 Gauss/cm (25 T/m)
  • Maximum MR whole-body-averaged specific absorption rate (SAR) of
    • 2 W/kg for landmarks (i.e. center of RF coil) above the umbilicus
    • 1 W/kg for landmarks below the umbilicus and above the mid-thigh
    • 0.5 W/kg for landmarks below the mid-thigh

Under the scan conditions defined above, the Supera™ stent is expected to produce a maximum temperature rise of 7.6 °C after 15 minutes of continuous scanning.

In nonclinical testing, the image artifact caused by the device extends approximately 2 cm from the Supera™ stent when imaged with a gradient echo or spin echo sequence and a 3T MRI system.

Potential Adverse Events 

Potential adverse events include, but are not limited to:

  • Abrupt closure
  • Allergic reaction (contrast medium; drug; stent material)
  • Amputation or limb loss
  • Aneurysm or pseudoaneurysm in vessel or at vascular access site
  • Angina or coronary ischemia
  • Arrhythmia (including premature beats, bradycardia, atrial or ventricular tachycardia, atrial or ventricular fibrillation)
  • Arteriovenous fistula
  • Bleeding complications requiring transfusion or surgical intervention
  • Death
  • Detachment of a system component or implantation in an unintended site
  • Embolization, arterial or other (e.g. air, tissue, plaque, thrombotic material, or stent)
  • Emergent surgery
  • Fever
  • Hematoma or hemorrhagic event, with or without surgical repair
  • Hyperperfusion syndrome
  • Hypertension / Hypotension
  • Infection
  • Myocardial infarction
  • Pain (leg, foot, and/or insertion site)
  • Partial stent deployment
  • Peripheral nerve injury
  • Pulmonary embolism
  • Renal failure or insufficiency
  • Restenosis of vessel in stented segment
  • Shock
  • Stent malapposition or migration, which may require emergency surgery to remove stent
  • Stent strut fracture
  • Thrombosis or occlusion
  • Stroke
  • Transient ischemic attack
  • Venous thromboembolism
  • Vessel dissection, perforation or rupture
  • Vessel spasm or recoil
  • Worsening claudication or rest pain

MAT-2103597 v3.0